Studies suggest that CK‐18 fragments can differentiate between NASH and NAFLD,30, 31, 32 with increases in hepatocellular apoptosis present in NASH, but not in NAFLD.33 Here, KRT18 is linked to metabolic dysfunction-associated steatotic liver disease.